Clinical Trial Update: Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age [Phase 4]

View source ↗

Summary

The Phase 4 study evaluating the optimal posology of gonadotrophins in patients with age-related insufficient ovarian response has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Gonadotrophins (gonadotropins)

Snippet

Sponsor: Centre Hospitalier Chretien | Conditions: Infertility | Phase 4 | Status: WITHDRAWN